Martin Puhr

3.0k total citations
60 papers, 2.3k citations indexed

About

Martin Puhr is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Martin Puhr has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Martin Puhr's work include Prostate Cancer Treatment and Research (32 papers), Cancer, Lipids, and Metabolism (12 papers) and Estrogen and related hormone effects (12 papers). Martin Puhr is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Cancer, Lipids, and Metabolism (12 papers) and Estrogen and related hormone effects (12 papers). Martin Puhr collaborates with scholars based in Austria, Germany and Italy. Martin Puhr's co-authors include Zoran Čulig, Helmut Klocker, Hannes Neuwirt, Julia Hoefer, Georg Schäfer, Holger H.H. Erb, Isabel Heidegger, Iris E. Eder, Alfred Hobisch and Frédéric R. Santer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Martin Puhr

60 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Puhr Austria 27 1.2k 926 791 786 304 60 2.3k
Shanshan Bai China 20 1.3k 1.1× 480 0.5× 716 0.9× 693 0.9× 343 1.1× 51 2.1k
Wendy J. Huss United States 22 981 0.8× 711 0.8× 664 0.8× 497 0.6× 202 0.7× 40 1.8k
Anne Pradines France 30 1.7k 1.4× 1.1k 1.2× 609 0.8× 1.0k 1.3× 231 0.8× 77 2.9k
Bora Gürel United States 24 1.4k 1.2× 661 0.7× 1.5k 1.9× 722 0.9× 205 0.7× 57 2.9k
Ruth Birbe United States 29 1.5k 1.3× 707 0.8× 427 0.5× 1.1k 1.5× 248 0.8× 50 2.7k
Mahmoud Toulany Germany 32 1.9k 1.6× 1.1k 1.2× 716 0.9× 603 0.8× 238 0.8× 59 3.0k
Shawn Brisbay United States 23 1.7k 1.4× 907 1.0× 599 0.8× 465 0.6× 232 0.8× 35 2.5k
Toshiyuki Sakamaki United States 19 2.1k 1.7× 1.0k 1.1× 315 0.4× 712 0.9× 236 0.8× 25 2.9k
Hugh Arnold United States 15 2.0k 1.7× 797 0.9× 412 0.5× 398 0.5× 214 0.7× 18 2.7k
Luke Gaughan United Kingdom 28 2.3k 2.0× 578 0.6× 731 0.9× 388 0.5× 164 0.5× 52 2.9k

Countries citing papers authored by Martin Puhr

Since Specialization
Citations

This map shows the geographic impact of Martin Puhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Puhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Puhr more than expected).

Fields of papers citing papers by Martin Puhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Puhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Puhr. The network helps show where Martin Puhr may publish in the future.

Co-authorship network of co-authors of Martin Puhr

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Puhr. A scholar is included among the top collaborators of Martin Puhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Puhr. Martin Puhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brunner, Edward, Francesco Baschieri, Georgios Fotakis, et al.. (2025). Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts. Journal of Experimental & Clinical Cancer Research. 45(1). 11–11. 1 indexed citations
2.
Heidegger, Isabel, Stefan Salcher, Piotr Tymoszuk, et al.. (2024). Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature. European Urology Oncology. 8(3). 652–662. 9 indexed citations
3.
Morales, Elisa, Martin Puhr, Sven Wach, et al.. (2024). MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer. Endocrinology. 165(10). 4 indexed citations
4.
Thomas, Christian, Martin Puhr, Wilbert Zwart, et al.. (2024). Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. Journal of Experimental & Clinical Cancer Research. 43(1). 194–194. 3 indexed citations
5.
Mehralivand, Sherif, Christian Thomas, Martin Puhr, et al.. (2024). New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of Translational Medicine. 22(1). 71–71. 10 indexed citations
6.
Brandt, Maximilian Peter, Olesya Vakhrusheva, Hubert Hackl, et al.. (2024). Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer. American Journal Of Pathology. 194(11). 2150–2162. 1 indexed citations
7.
Eigentler, Andrea, Florian Handle, Hubert Hackl, et al.. (2023). Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. Oncogene. 43(4). 235–247. 12 indexed citations
8.
Pardella, Elisa, Erica Pranzini, Matteo Parri, et al.. (2022). Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer. Cells. 11(24). 4026–4026. 22 indexed citations
9.
Vakhrusheva, Olesya, Holger H.H. Erb, Sascha D. Markowitsch, et al.. (2022). Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells. Frontiers in Oncology. 12. 789284–789284. 20 indexed citations
10.
Puhr, Martin, Andrea Eigentler, Florian Handle, et al.. (2021). Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Oncogene. 40(17). 3087–3100. 26 indexed citations
11.
Pircher, Andreas, Georg Schäfer, Andrea Eigentler, et al.. (2019). Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature. International Journal of Medical Sciences. 16(1). 115–124. 3 indexed citations
12.
Handle, Florian, Martin Puhr, Georg Schaefer, et al.. (2018). The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models. Molecular Cancer Therapeutics. 17(12). 2722–2731. 36 indexed citations
13.
Puhr, Martin, Julia Hoefer, Andrea Eigentler, et al.. (2017). The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clinical Cancer Research. 24(4). 927–938. 129 indexed citations
14.
Čulig, Zoran & Martin Puhr. (2017). Interleukin-6 and prostate cancer: Current developments and unsolved questions. Molecular and Cellular Endocrinology. 462(Pt A). 25–30. 90 indexed citations
15.
Ippolito, Luigi, Alberto Marini, Lorenzo Cavallini, et al.. (2016). Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget. 7(38). 61890–61904. 109 indexed citations
16.
Neuwirt, Hannes, Iris E. Eder, Martin Puhr, & Michael Rudnicki. (2012). SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner. Laboratory Investigation. 93(1). 123–134. 11 indexed citations
17.
Čulig, Zoran & Martin Puhr. (2011). Interleukin-6: A multifunctional targetable cytokine in human prostate cancer. Molecular and Cellular Endocrinology. 360(1-2). 52–58. 135 indexed citations
18.
19.
Puhr, Martin, Frédéric R. Santer, Hannes Neuwirt, et al.. (2009). Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways. Cancer Research. 69(18). 7375–7384. 77 indexed citations
20.
Neuwirt, Hannes, Martin Puhr, Ilaria T. Cavarretta, et al.. (2009). C. E. Alken Preis 2007: Androgene stimulieren die Expression von SOCS-3 und bewirken die Inhibition der Proliferation und Sekretion. Aktuelle Urologie. 40(4). 231–234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanshan Bai Breakdown of academic impact, for papers by Wendy J. Huss Breakdown of academic impact, for papers by Anne Pradines Breakdown of academic impact, for papers by Bora Gürel Breakdown of academic impact, for papers by Ruth Birbe Breakdown of academic impact, for papers by Mahmoud Toulany Breakdown of academic impact, for papers by Shawn Brisbay Breakdown of academic impact, for papers by Toshiyuki Sakamaki Breakdown of academic impact, for papers by Hugh Arnold Breakdown of academic impact, for papers by Luke Gaughan
Rankless by CCL
2026